Human embryonic kidney (
HEK) 293T cells, mouse melanoma B16-F10 cells, and mouse embryonic fibroblast
BALB/3T3 cells were obtained from the Bioresource Collection and Research Center (BCRC, Hsinchu City, Taiwan, ROC). These cells were cultured in
Dulbecco’s modified Eagle’s medium (DMEM; Invitrogen, Gaithersburg, MD, USA) supplemented with inactivated 10%
foetal bovine serum (FBS; Invitrogen) and 1%
penicillin–streptomycin amphotericin B (PSA; Biological industries, New York, NY, USA). Human natural killer NK-92 MI cells were grown in
alpha minimum essential medium (αMEM; Sigma-Aldrich, St. Louis, MO, USA) supplemented with 0.2 mM
inositol (Sigma-Aldrich), 0.2 mM
2-mercaptoethanol (Sigma-Aldrich), 0.02 mM
folic acid (Sigma-Aldrich), 12.5%
horse serum (Gibco BRL, Gaithersburg, MD, USA) and 12.5% FBS. All cells were incubated at 37 °C in an atmosphere of 5% CO
2.
Male C57BL/6 mice (6–8 weeks old) were purchased from the National Laboratory Animal Center (NLAC, Taipei City, Taiwan, ROC).
1,2-Dioleoyl-
sn-glycero-3-phosphocholine (DOPC) (Avanti Polar Lipids, Inc., Alabaster, AL, USA), 1,2-dilauroyl-
sn-glycero-3-phosphocholine (DLPC) (Avanti Polar Lipids, Inc.) and polyethylene glycol (PEG, MW 1.500) (Shimo-Meguro, Meguro-Ku, Tokyo, Japan), PEG (MW 8.000, Sigma-Aldrich) and polyethylenimine (PEI, branched, MW 25.000, Sigma-Aldrich) were purchased to prepare LPPC.
Ho S.Y., Chen P.R., Chen C.H., Tsai N.M., Lin Y.H., Lin C.S., Chuang C.H., Huang X.F., Chan Y.L., Liu Y.K., Chung C.H., Weng S.L, & Liao K.W. (2020). Lipoplex-based targeted gene therapy for the suppression of tumours with VEGFR expression by producing anti-angiogenic molecules. Journal of Nanobiotechnology, 18, 58.